TCM
Tang Capital Management Portfolio holdings
AUM
$1.98B
This Quarter Return
-19.57%
1 Year Return
+21.62%
3 Year Return
+290.69%
5 Year Return
+284.46%
10 Year Return
+928.34%
AUM
$355M
AUM Growth
+$355M
(-46%)
Cap. Flow
-$16.5M
Cap. Flow
% of AUM
-4.63%
Top 10 Holdings %
Top 10 Hldgs %
98.85%
Holding
12
New
1
Increased
1
Reduced
1
Closed
1
Top Buys
| 1 |
VINC
Vincerx Pharma, Inc. Common Stock
VINC
|
$9.65M |
| 2 |
VINCW
Vincerx Pharma, Inc. Warrant
VINCW
|
$2.76M |
Top Sells
| 1 |
Rocket Pharmaceuticals
RCKT
|
$19.2M |
| 2 |
VINCU
Vincerx Pharma, Inc. Unit
VINCU
|
$9.63M |
Sector Composition
| 1 | Healthcare | 98.85% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
|
1
Rocket Pharmaceuticals
RCKT
$354M
| $112M | 31.61% | 2,531,800 -433,685 | -15% | -$19.2M |
|
2
AnaptysBio
ANAB
$569M
| $56.6M | 15.94% | 2,628,678 | – | – |
|
3
Aptevo Therapeutics
APVO
$5.39M
| $53.7M | 15.11% | 1,760,000 | – | – |
|
|
ODT
4
DELISTED
Odonate Therapeutics, Inc. Common Stock
ODT
| $53.1M | 14.93% | 15,514,566 | – | – |
|
|
LJPC
5
DELISTED
La Jolla Pharmaceutical Company
LJPC
| $39.9M | 11.22% | 9,405,490 | – | – |
|
|
VINC
6
DELISTED
Vincerx Pharma, Inc. Common Stock
VINC
| $9.65M | 2.72% | +500,000 | New | +$9.65M |
|
7
Coherus Oncology, Inc. Common Stock
CHRS
$135M
| $9.5M | 2.67% | 650,000 | – | – |
|
8
Relmada Therapeutics
RLMD
$37.2M
| $7.04M | 1.98% | 200,000 | – | – |
|
9
Tango Therapeutics
TNGX
$747M
| $5.21M | 1.47% | 468,750 | – | – |
|
10
Equillium
EQ
$62.2M
| $4.29M | 1.21% | 600,000 | – | – |
|
|
VINCW
11
DELISTED
Vincerx Pharma, Inc. Warrant
VINCW
| $4.1M | 1.15% | 1,014,368 +684,163 | +207% | +$2.76M |
|
|
VINCU
12
DELISTED
Vincerx Pharma, Inc. Unit
VINCU
| – | – | -500,000 | Closed | -$9.63M |
|